Case Studies  /  Commercial & Digital Health Strategy

Informing digital health strategy for R&D in immunology


  • A top 3 biopharma company sought deep dive evaluation of digital therapeutic trends and emerging innovation across 13 immunology indications
  • The client requested an analysis of digital measures across immunology clinical trials and best practice considerations


  • Explored digital therapeutic competitive activity and benchmarked clinical validation, regulatory status & biopharma partnerships
  • Probed business model trends including overall shift from DTC to payer and employer coverage, evolving digital formularies and payer drivers and barriers
  • Evaluated pharma/digital health partnerships


  • Our team synthesized implications for the client’s digital health strategy across immunology and by indication
  • Output was used to help sharpen immunology digital health strategy and launch several initiatives

© 2023 Opus Strategy, LLC